Getinge Group
| Company type | Publicly traded Aktiebolag |
|---|---|
| Nasdaq Stockholm: GETI B | |
| ISIN | SE0000202624 |
| Industry | Health care |
| Founded | 1904 |
| Headquarters | Gothenburg, Sweden |
Key people | Johan Malmquist (Chairman), Mattias Perjos (President and CEO) |
| Products | Disinfectors, sterilisation equipment, surgical tables, ventilators, heart-lung machines, anesthesia, bioreactors, hospital digital integration solutions |
| Revenue | SEK 34.7 billion (2024) |
| SEK 2,854 million(2024) | |
| SEK 1,654 million (2024) | |
| Total assets | SEK 63,918 million (end 2024) |
| Total equity | SEK 33,210 million (end 2024) |
Number of employees | ~12,000 (end 2024) |
| Subsidiaries | |
| Website | getinge |
Getinge AB is a publicly traded Swedish medical technology company. The company produces and distributes medical products and equipment for the healthcare and life sciences industries. The company is divided into three business areas: Life Science, Acute Care Therapies, and Surgical Workflows. The group employs approximately 12,000 people worldwide. The CEO of the company is Mattias Perjos, and the chairman of the board is Johan Malmquist. With a sales share of around 40%, the United States is by far the most important market for the company due to significantly higher prices and margins there. China and various Western European countries follow.